Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.

MLA

Djingarey, Mamoudou H., et al. “Effectively Introducing a New Meningococcal A Conjugate Vaccine in Africa: The Burkina Faso Experience.” Vaccine, vol. 30 Suppl 2, May 2012, pp. B40–45. EBSCOhost, https://doi.org/10.1016/j.vaccine.2011.12.073.

APA

Djingarey, M. H., Barry, R., Bonkoungou, M., Tiendrebeogo, S., Sebgo, R., Kandolo, D., Lingani, C., Preziosi, M.-P., Zuber, P. L. F., Perea, W., Hugonnet, S., Dellepiane de Rey Tolve, N., Tevi-Benissan, C., Clark, T. A., Mayer, L. W., Novak, R., Messonier, N. E., Berlier, M., Toboe, D., … Laforce, F. M. (2012). Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine, 30 Suppl 2, B40–B45. https://doi.org/10.1016/j.vaccine.2011.12.073

Chicago

Djingarey, Mamoudou H, Rodrigue Barry, Mete Bonkoungou, Sylvestre Tiendrebeogo, Rene Sebgo, Denis Kandolo, Clement Lingani, et al. 2012. “Effectively Introducing a New Meningococcal A Conjugate Vaccine in Africa: The Burkina Faso Experience.” Vaccine 30 Suppl 2 (May): B40–45. doi:10.1016/j.vaccine.2011.12.073.